Experts

Elizabeth Mannick

Director, Regulatory Affairs, Regulatory Strategy and Project Development

Education

MD, Yale University School of Medicine
MS, Harvard School of Public Health
BA, Harvard College

Dr. Elizabeth Mannick is a physician with more than 20 years of experience in clinical medicine (pediatric and adult gastroenterology) practicing in urban academic and rural private practice settings. She also has 6 years of combined experience in the Food and Drug Administration and in regulatory affairs and drug safety in the pharmaceutical industry. Dr. Mannick has reviewed and spearheaded the filing of Investigational New Drug Applications (INDs), Clinical Trial Applications (CTAs), Biologics License Applications and New Drug Applications (NDAs).

While at RTI, Dr. Mannick has worked on a variety of projects with government agencies including NIH, ARPA-H, CMS and BARDA as well as consulting for start-up companies.

Publications

View All Publications

Article

Living related liver transplant in a patient with argininosuccinic aciduria and cirrhosis: Metabolic follow-up

April 2008

Article

Altered phenotype of dextran sulfate sodium colitis in interferon regulatory factor-1 knock-out mice

March 2005

Article

Gene expression in gastric biopsies from patients infected with Helicobacter pylori

December 2004

Article

Gene expression in mononuclear cells from patients with inflammatory bowel disease

September 2004

Related Capabilities

Solution

Quality Assurance and Regulatory Compliance

Health

Health Care Transformation

Maternal Health in the United States

Get in Touch

To speak to this expert or inquire about RTI services, you can reach us at +1 919 541 6000 or use the contact form below. For media inquiries, please reach out to our Media Relations team at news@rti.org.